Schmid Gerald, Wojciechowski Jacek, Wesierska-Gadek Józefa
Cell Cycle Regulation Group, Division: Institute of Cancer Research, Department of Medicine I, Vienna Medical University, Vienna, Austria.
Acta Biochim Pol. 2005;52(3):713-9. Epub 2005 Aug 4.
We recently observed an interaction between poly(ADP-ribose) polymerase-1 (PARP-1) and the tumor suppressor p53 protein. However, more extensive studies on both proteins, especially those on characterization of their domains involved in the interaction were difficult due to very low expression levels of p53 in mammalian cells. Therefore, we generated recombinant proteins for such studies. To clarify which domains of human PARP-1 and of human wild-type (wt) p53 were involved in this protein-protein interaction, we generated baculoviral constructs encoding full length or distinct functional domains of both proteins. Full length PARP-1 was simultaneously coexpressed in insect cells with full length wt p53 protein or its distinct truncated fragments and vice versa. Reciprocal immunoprecipitation of Sf9 cell lysates revealed that the central and carboxy-terminal fragments of p53 each were sufficient to confer binding to PARP-1, whereas the amino-terminal part harbouring the transactivation functional domain was dispensable. On the other hand, the amino-terminal and central fragments of PARP-1 were both necessary for complex formation with p53 protein. Since the most important features of p53 protein are regulated by phosphorylation, we addressed the question whether its phosphorylation is essential for the binding between the two proteins. Baculovirally expressed wt p53 was post-translationally modified. At least six distinct p53 isomers were resolved by immunoblotting following two-dimensional separation of baculovirally expressed wt p53 protein. Using specific phospho-serine antibodies, we identified phosphorylation of baculovirally expressed p53 protein at five distinct sites. To define the role of p53 phosphorylation, pull-down assays using untreated and dephosphorylated p53 protein were performed. Dephosphorylated p53 failed to bind PARP-1, indicating that complex formation between the two proteins was regulated by phosphorylation of p53. The marked phosphorylation of p53 at Ser392 observed in unstressed cells suggests that the phosphorylated carboxy-terminal part of p53 undergoes complex formation with PARP-1 resulting in masking of the NES and thereby preventing its export.
我们最近观察到聚(ADP - 核糖)聚合酶 -1(PARP -1)与肿瘤抑制蛋白p53之间存在相互作用。然而,由于p53在哺乳动物细胞中的表达水平非常低,对这两种蛋白质进行更广泛的研究,尤其是对其参与相互作用的结构域进行表征的研究很困难。因此,我们制备了用于此类研究的重组蛋白。为了阐明人PARP -1和人野生型(wt)p53的哪些结构域参与了这种蛋白质 - 蛋白质相互作用,我们构建了杆状病毒载体,分别编码这两种蛋白质的全长或不同的功能结构域。全长PARP -1与全长wt p53蛋白或其不同的截短片段在昆虫细胞中同时共表达,反之亦然。对Sf9细胞裂解物进行相互免疫沉淀分析表明,p53的中央和羧基末端片段各自足以与PARP -1结合,而含有反式激活功能结构域的氨基末端部分则是不必要的。另一方面,PARP -1的氨基末端和中央片段对于与p53蛋白形成复合物都是必需的。由于p53蛋白的最重要特征受磷酸化调节,我们探讨了其磷酸化对于这两种蛋白质之间结合是否至关重要的问题。杆状病毒表达的wt p53经过翻译后修饰。在对杆状病毒表达的wt p53蛋白进行二维分离后,通过免疫印迹法分辨出至少六种不同的p53异构体。使用特异性磷酸丝氨酸抗体,我们鉴定出杆状病毒表达的p53蛋白在五个不同位点发生磷酸化。为了确定p53磷酸化的作用,我们使用未处理的和去磷酸化的p53蛋白进行了下拉分析。去磷酸化的p53无法与PARP -1结合,这表明这两种蛋白质之间的复合物形成受p53磷酸化的调节。在未受应激的细胞中观察到的p53在Ser392处的显著磷酸化表明,p53磷酸化的羧基末端部分与PARP -1形成复合物,导致核输出信号(NES)被掩盖,从而阻止其输出。